Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 21Recruiting 4Unknown 3Terminated 3Withdrawn 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 3Lymphoid 3Genitourinary 3CNS 3Plasma cell 2Myeloid 2Breast 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Prostatic Neoplasms 3Hot Flashes 1Fatigue 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Therapeutics × Genitourinary × Clear all
NCT00415246 2019-11-22

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

Ipsen

Phase 3 Terminated
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT00244894 2017-04-28

Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer

OHSU Knight Cancer Institute

Phase NA Terminated
22 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms, Hot Flashes

NCT00312442 2010-06-02

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

STEBA France

Phase 2/3 Terminated
16 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡